David Barros
Publications by Year
Research Areas
Tuberculosis Research and Epidemiology, Biochemical and Molecular Research, Cancer therapeutics and mechanisms, Computational Drug Discovery Methods, Antibiotic Resistance in Bacteria
Most-Cited Works
- → Fueling Open‐Source Drug Discovery: 177 Small‐Molecule Leads against Tuberculosis(2013)308 cited
- → Identification of Novel Imidazo[1,2-a]pyridine Inhibitors Targeting M. tuberculosis QcrB(2012)177 cited
- → Discovery of a Potent and Specific M. tuberculosis Leucyl-tRNA Synthetase Inhibitor: (S)-3-(Aminomethyl)-4-chloro-7-(2-hydroxyethoxy)benzo[c][1,2]oxaborol-1(3H)-ol (GSK656)(2017)159 cited
- → Identification and Activity of a Series of Azole-based Compounds with Lactate Dehydrogenase-directed Anti-malarial Activity(2004)142 cited
- → Tetrahydropyrazolo[1,5-a]Pyrimidine-3-Carboxamide and N-Benzyl-6′,7′-Dihydrospiro[Piperidine-4,4′-Thieno[3,2-c]Pyran] Analogues with Bactericidal Efficacy against Mycobacterium tuberculosis Targeting MmpL3(2013)138 cited
- → Discovery of Novel Oral Protein Synthesis Inhibitors of Mycobacterium tuberculosis That Target Leucyl-tRNA Synthetase(2016)118 cited
- → Rapid Cytolysis of Mycobacterium tuberculosis by Faropenem, an Orally Bioavailable β-Lactam Antibiotic(2014)105 cited
- → Identification of KasA as the cellular target of an anti-tubercular scaffold(2016)96 cited
- → Repurposing clinically approved cephalosporins for tuberculosis therapy(2016)89 cited
- → Antitubercular drugs for an old target: GSK693 as a promising InhA direct inhibitor(2016)81 cited